You are here: Home > For Researchers > Projects > SQUAD - Molecular and computational biology of quorum signaling in bacterial pathogens: Salmonella

SQUAD - Molecular and computational biology of quorum signaling in bacterial pathogens: Salmonella

From 01-10-2002 to 28-02-2007

Description

The acquirement of resistance of pathogenic bacteria to common antibiotics and the development of multidrug resistant strains is raising alarms in healthcare and fueling demand for new antibiotics. Moreover, antibiotics have a borad range effect, killing also the beneficial intestinal microflora. Alternative more sustainable approaches to cope with these infectious bacteria are needed. An alternative way to combat bacterial infetions could be based on the breakthrough discovery that a wide variety of pathogenic bacteria communicate via a common chemical 'language' required to coordinate and regulate the onset of pathogenesis. This bacterial communication is termed quorum sensing. A major goal of this project is to gain insight into the mechanism of quorum sensing since it indefinitely is the clue to a plethora of distinct intriguing phenomena such as bacterial pathogenesis.

Team

Financing

Funding: IWT - Agentschap voor Innovatie door Wetenschap en Technologie 

Program/Grant Type: IWT other - Other IWT Grants

Events

2/09/2024:
PhD defense - Martijn Oldenhof
Machine Learning for Advanced Chemical Analysis and Structure Recognition in Drug Discovery


3/09/2024:
Meet the Jury Igor Tetko on Advanced Machine Learning in Drug Discovery


12/09/2024:
Multimodal analysis of cell-free DNA for sensitive cancer detection in low-coverage and low-sample settings
Seminar by Antoine Passemiers


More events

News

STADIUS Alumni Herman Verrelst – new CEO of Biocartis

08 June 2017

Herman Verrelst, the founder of KU Leuven spin-off Cartagenia, who has been working in Silicon Valley, US for the last few years will be returning to Belgium to follow the steps of Rudi Pauwels as CEO of the Belgian diagnostic company, Biocartis.


Supporting healthcare policymaking via machine learning – batteries included!

29 May 2017

STADIUS takes the lead in the data analytics efforts in an ambitious European Project MIDAS.


Marc Claesen gives an interview about his PhD for the magazine of the Faculty of Engineering Sciences "Geniaal"

10 February 2017

Did you know that in Belgium approximately one third of type 2 diabetes patients are unaware of their condition?


Joos Vandewalle is nieuwe voorzitter KVAB

09 October 2016

Op 5 oktober 2016 heeft de Algemene Vergadering van de Academie KVAB Joos Vandewalle verkozen tot voorzitter van de KVAB.


More news

Logo STADIUS